Avilar Therapeutics
PrivateLast Round
Seed
Feb 16, 2023
Total Funding Raised
$135M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Avilar Therapeutics is a biotechnology company that develops innovative extracellular protein degraders to target and eliminate disease-causing proteins from circulation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avilar Therapeutics Comparables
Compare Avilar Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Draupnir Bio | 87% | |
| Lycia Therapeutics | 86% | |
| GlycoEra | 83% | |
Avilar Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 16, 2023 | ||||
| Seed | Nov 18, 2021 |
Avilar Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Seed |
| Medical Excellence Capital | Seed |
| Astellas Venture Management | Seed |
| Sanofi Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 39% MoM, reaching 2.3K.
- Feb 16, 2023
$15M round with participation from RA Capital Management.
Avilar Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Avilar Therapeutics's valuation, stock price, and market status.